ORCID as entered in ROS
https://orcid.org/0000-0002-0011-3924
Select Publications
Journal articles
, 1998, 'Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer', European Journal of Gastroenterology & Hepatology, 10, pp. 626 - 626, http://dx.doi.org/10.1097/00042737-199807000-00025
, 1997, 'Alterations in gastric physiology in Helicobacter pylori infection: Causes of different diseases or all epiphenomena?', Italian Journal of Gastroenterology and Hepatology, 29, pp. 459 - 464
, 1997, 'The role of Helicobacter pylori in the pathophysiology of duodenal ulcer disease and gastric cancer', Seminars in Gastrointestinal Disease, 8, pp. 142 - 155
, 1997, 'The role of H. Pylori infection in the pathophysiology of duodenal ulcer disease', Journal of Physiology and Pharmacology, 48, pp. 287 - 295
, 1997, 'Helicobacter pylori infection and chronic gastric acid hyposecretion', Gastroenterology, 113, pp. 15 - 24, http://dx.doi.org/10.1016/S0016-5085(97)70075-1
, 1997, 'The Glasgow Dyspepsia Severity Score - A tool for the global measurement of dyspepsia (multiple letters) [1]', European Journal of Gastroenterology and Hepatology, 9, pp. 413 - 414, http://dx.doi.org/10.1097/00042737-199704000-00018
, 1997, 'The Helicobacter pylori breath test: A surrogate marker for peptic ulcer disease in dyspeptic patients', Gut, 40, pp. 302 - 306, http://dx.doi.org/10.1136/gut.40.3.302
, 1996, 'Marked rebound acid hypersecretion after treatment with ranitidine', American Journal of Gastroenterology, 91, pp. 355 - 359
, 1996, 'Gastrin-releasing peptide, acid secretion, Helicobacter pylori, and duodenal ulcer: Another epiphenomenon? [4]', Gastroenterology, 110, pp. 1325 - 1326, http://dx.doi.org/10.1053/gast.1996.v110.agast961325
, 1996, 'Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patients with duodenal ulcer', Gastroenterology, 110, pp. 717 - 724, http://dx.doi.org/10.1053/gast.1996.v110.pm8608880
, 1996, 'The Glasgow Dyspepsia Severity Score - A tool for the global measurement of dyspepsia', European Journal of Gastroenterology and Hepatology, 8, pp. 967 - 971, http://dx.doi.org/10.1097/00042737-199610000-00006
, 1995, 'A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients', Gut, 36, pp. 534 - 538, http://dx.doi.org/10.1136/gut.36.4.534
, 1995, 'Gastrin releasing peptide and its value in assessing gastric secretory function', Alimentary Pharmacology & Therapeutics, 9, pp. 341 - 347, http://dx.doi.org/10.1111/j.1365-2036.1995.tb00392.x
, 1995, 'Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease', Gastroenterology, 109, pp. 681 - 691, http://dx.doi.org/10.1016/0016-5085(95)90374-7
, 1995, 'Reply', Gastroenterology, 108, pp. 619, http://dx.doi.org/10.1016/0016-5085(95)90114-0
, 1995, 'Effect of H pylori eradication on the severity of dyspeptic symptoms in du patients - a one year follow up study', Gastroenterology, 108, pp. A88 - A88, http://dx.doi.org/10.1016/0016-5085(95)23016-5
, 1995, 'H pylori infection and dyspepsia within the general population', Gastroenterology, 108, pp. A88 - A88, http://dx.doi.org/10.1016/0016-5085(95)23015-7
, 1994, 'Duodenal ulcer healing drugs', The Lancet, 343, pp. 915 - 916, http://dx.doi.org/10.1016/S0140-6736(94)90033-7
, 1994, 'Helicobacter pylori eradication, duodenal ulcer healing, and gastric secretory state [1]', Gut, 35, pp. 571, http://dx.doi.org/10.1136/gut.35.4.571
, 1994, 'Low prevalence of Helicobacter pylori in inflammatory bowel disease: Association with sulphasalazine', Gut, 35, pp. 1385 - 1388, http://dx.doi.org/10.1136/gut.35.10.1385
, 1994, 'Plasma gastrin concentrations are normal in patients with colorectal neoplasia and unaltered following tumor resection', Gastroenterology, 106, pp. 1263 - 1270, http://dx.doi.org/10.1016/0016-5085(94)90018-3
, 1994, 'The GRP test: A new clinical test of acid secretion — reproducibility data', European Journal of Gastroenterology and Hepatology, 6, pp. 417 - 421
, 1994, 'Reply', Gut, 35, pp. 571 - 571, http://dx.doi.org/10.1136/gut.35.4.571-a
, 1993, 'A study of the pathogenesis of Helicobacter pylon negative chronic duodenal ulceration', Gut, 34, pp. 762 - 768
, 1993, 'Eradicating Helicobacter pylon infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer', Gut, 34, pp. 1060 - 1065, http://dx.doi.org/10.1136/gut.34.8.1060
, 1993, 'Omeprazole inhibits colorectal carcinogenesis induced by azoxymethane in rats', Gut, 34, pp. 1559 - 1565, http://dx.doi.org/10.1136/gut.34.11.1559
, 1989, 'Regulation of hepatic synthesis of C3 and C4 during the acute‐phase response in the rat', European Journal of Immunology, 19, pp. 1405 - 1412, http://dx.doi.org/10.1002/eji.1830190809
, 1987, 'Effect of rifampicin on haem and bilirubin metabolism in man.', British Journal of Clinical Pharmacology, 23, pp. 553 - 559, http://dx.doi.org/10.1111/j.1365-2125.1987.tb03091.x
, 1987, 'Porphyrin metabolism and haem biosynthesis in Gilbert's syndrome', Gut, 28, pp. 125 - 130
Conference Papers
, 2023, 'IDDF2023-ABS-0223 Modulating the gut microbiota alters the gut-liver immune environment in a preclinical model of HCC', in Gut – IDDF Young Investigator Award, BMJ Publishing Group Ltd and British Society of Gastroenterology, presented at
, 2023, 'IDDF2023-ABS-0249 Implications of oro-pharyngeal dysbiosis in head and neck cancer: oral microbiome and chemoradiation-related complications', in Basic Gastroenterology, BMJ Publishing Group Ltd and British Society of Gastroenterology, presented at
, 2019, 'IDDF2019-ABS-0188 Gut microbiota modulates the chemopreventive efficacy of aspirin on colorectal cancer through impact on aspirin bioavailability', in Basic gastroenterology, BMJ Publishing Group Ltd and British Society of Gastroenterology, presented at
, 2019, 'IDDF2019-ABS-0213 Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after helicobacter pylori eradication- a multicentre randomised trial', in Gut – IDDF Young Investigator Award, BMJ Publishing Group Ltd and British Society of Gastroenterology, presented at
, 2018, 'Efficacies of genotypic resistance-guided versus empirical therapy for refractory Helicobacter pylori infection: A randomized controlled trial', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 80 - 80, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450260400094&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'ELUCIDATING THE PATHOGENIC POTENTIAL OF THE INTESTINAL PATHOGEN CAMPYLOBACTER SHOWAE', in GUT, BMJ PUBLISHING GROUP, ENGLAND, Manchester, pp. A138 - A138, presented at
, 2016, 'Transporters for Antiretroviral Drugs in Colorectal CD4+T Cells and Circulating alpha 4 beta 7 Integrin CD4+T Cells: Implications for HIV Microbicides', in AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT, INC, IL, Chicago, pp. 353 - 353, presented at
, 2016, 'Toll-like receptor 8 polymorphisms in Helicobacter pylori infection', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 637 - 637, presented at
, 2016, 'CYTOPLASMIC EXPRESSION OF HMGB1 IS ASSOCIATED WITH EARLY COLORECTAL CARCINOGENESIS', in GUT, BMJ PUBLISHING GROUP, pp. A192 - A192, http://dx.doi.org/10.1136/gutjnl-2016-312388.354
, 2014, 'Characterisation of Drug Transporter Gene Expression in Colorectal Tissue and Cell Lines: Induction with Anti-retrovirals for Microbicide Optimization', in AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT, INC, SOUTH AFRICA, Cape Town, pp. A201 - A201, presented at
, 2014, 'GENOME-WIDE EPIGENETIC ANALYSIS IN CHILDHOOD-ONSET CROHN'S DISEASE IMPLICATES MIR21', in GUT, BMJ PUBLISHING GROUP, ENGLAND, Manchester, pp. A2 - A2, presented at
, 2014, 'Genome-Wide Analysis of DNA Methylation in Low-Grade Colorectal Adenomas and Normal Colonic Mucosa', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, IL, Chicago, pp. S165 - S165, presented at
, 2013, 'ASSESSMENT OF BACTERIAL DIVERSITY IN COLORECTAL ADENOMATOUS POLYPS', in GUT, BMJ PUBLISHING GROUP, SCOTLAND, Glasgow, pp. A134 - A135, presented at
, 2013, 'DEVELOPMENT AND INITIAL VALIDATION OF PROGNOSTIC SCORING SYSTEMS FOR LOWER GASTROINTESTINAL BLEEDING', in GUT, BMJ PUBLISHING GROUP, SCOTLAND, Glasgow, pp. A57 - A57, presented at
, 2013, 'EVALUATION OF FAECAL ASPIRATE AS A PROXY FOR COLONOSCOPY BIOPSY SAMPLING TO ASSESS MICROBIAL DIVERSITY', in GUT, BMJ PUBLISHING GROUP, SCOTLAND, Glasgow, pp. A135 - A135, presented at
, 2013, 'THE MICROAEROPHILIC MICROBIOTA OF DE-NOVO PAEDIATRIC INFLAMMATORY BOWEL DISEASE: THE BISCUIT STUDY', in GUT, BMJ PUBLISHING GROUP, SCOTLAND, Glasgow, pp. A31 - A31, presented at
, 2013, 'THE ROLE OF THE FUNGAL MICROBIOTA IN THE PATHOGENESIS OF DE-NOVO PAEDIATRIC INFLAMMATORY BOWEL DISEASE USING NEXT GENERATION SEQUENCING', in GUT, BMJ PUBLISHING GROUP, SCOTLAND, Glasgow, pp. A32 - A32, presented at
, 2013, 'Assessment of Bacterial Diversity in Colorectal Adenomatous Polyps', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, FL, Orlando, pp. S348 - S348, presented at
, 2013, 'Evaluation of Fecal Aspirate As a Proxy for Colonoscopy Biopsy Sampling to Assess Microbial Diversity', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, FL, Orlando, pp. S832 - S832, presented at
, 2013, 'The Role of the Fungal Microbiota in the Pathogenesis of De-Novo Pediatric Inflammatory Bowel Disease Using Next Generation Sequencing', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, FL, Orlando, pp. S826 - S826, presented at
, 2012, 'Genetic Variation in C20orf54, PLCE1 and MUC1 and Risk of Upper Gastrointestinal Cancers in Caucasian Populations', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, pp. S634 - S634, presented at
Filter by type
https://orcid.org/0000-0002-0011-3924